| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.708 | 14.718 | 14.467 | 18.825 | 18.109 | 20.166 | 76.559 |
| Total Income - EUR | - | - | - | 5.708 | 14.718 | 14.467 | 18.825 | 30.413 | 21.227 | 76.569 |
| Total Expenses - EUR | - | - | - | 5.800 | 4.890 | 11.100 | 10.204 | 20.300 | 23.294 | 43.739 |
| Gross Profit/Loss - EUR | - | - | - | -91 | 9.828 | 3.367 | 8.621 | 10.113 | -2.067 | 32.830 |
| Net Profit/Loss - EUR | - | - | - | -262 | 9.387 | 2.949 | 8.056 | 9.570 | -2.540 | 27.073 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oncogyn Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.828 | 1.111 | 1.366 | 23.059 | 16.882 | 10.782 |
| Current Assets | - | - | - | 474 | 8.069 | 11.156 | 18.676 | 1.614 | 1.948 | 25.285 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 248 | 365 | 2.067 | 1.160 | 250 | 303 | 7.593 |
| Cash | - | - | - | 226 | 7.705 | 9.089 | 17.515 | 1.363 | 1.645 | 17.692 |
| Shareholders Funds | - | - | - | -219 | 9.172 | 11.947 | 19.738 | 9.619 | 7.049 | 27.121 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 694 | 725 | 321 | 304 | 15.054 | 11.781 | 8.946 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncogyn Center S.r.l.